Charles River Laboratories | CRL - Operating Expenses



Charles River Laboratories reported $899.8M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Agilent USD 1.38B 10M Jul/2025
Align Technology USD 849.42M 1.25M Jun/2025
Bio-Rad Laboratories USD 574.5M 12.8M Jun/2025
Bruker USD 785.5M 15.9M Jun/2025
Cardinal Health USD 59.53B 5.38B Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Cigna USD 65.21B 1.72B Jun/2025
CVS Health USD 96.53B 5.32B Jun/2025
Danaher USD 5.18B 718M Jun/2025
Dentsply International USD 825M 9M Jun/2025
Elevance Health USD 47.14B 1.05B Jun/2025
Galapagos EUR 122.32M 111.37M Jun/2025
Hologic USD 762.9M 249.4M Jun/2025
Humana USD 31.29B 1.19B Jun/2025
Illumina USD 845M 65M Jun/2025
Incyte USD 904.7M 56.97M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Laboratory Of America USD 3.06B 51.8M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
McKesson USD 96.74B 7.51B Jun/2025
Merck EUR 4.22B 49M Jun/2025
Mettler Toledo International USD 717.51M 35.71M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Quest Diagnostics USD 2.32B 17M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
United Therapeutics USD 521.7M 110.1M Jun/2025
UnitedHealth USD 106.47B 6B Jun/2025
Waters USD 583.12M 73.16M Jun/2025
West Pharmaceutical Services USD 612.8M 21.8M Jun/2025